Clinical Trial Update: Effects of MK7418 on Diuresis and Renal Function in Congestive Heart Failure Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating MK7418 for diuresis and renal function in patients with congestive heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Renal Impairment

Drugs mentioned

• MK7418

Snippet

Sponsor: NovaCardia, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Conditions: Congestive Heart Failure, Renal Impairment | Phase 2 | Status: COMPLETED